Livongo Health Inc.
18.76 - 151.05
Echofin Members Consensus
PM Conference Updates: $TDOC raises 2020 revenue guidance to $1,091 to $1,093M from prior range of 1,080 to 1,090M. Updates visit guidance to 10.6M from previous range of 10.4 to 10.6M. Nearing 50% penetration of F500. Also announced an expansion of $LVGO + $DXCM partnership.
Next Dividend Date
Livongo Health, Inc. engages in the development and operation of consumer digital health platform. It offers Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008 and is headquartered in Mountain View, CA.
CEO: Zane M. Burke
HQ: 150 West Evelyn Avenue Mountain View, 94041 CA